Altamira Therapeutics Ltd (CYTO) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Altamira Therapeutics Ltd   (NASDAQ: CYTO)

Altamira Therapeutics Ltd Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYTO Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q4 MRQ) - 68.77 % 57.15 % 52.58 %
Gross Margin (Q4 TTM) - 66.43 % 53.45 % 11.14 %
Gross Profit Margin 5 Yr. Avg. - 60.58 % 52 % 32.14 %
EBITDA Margin (Q4 MRQ) - 18.3 % 17.84 % 13.41 %
EBITDA Margin (Q4 TTM) - 18.27 % 15.59 % 17.23 %
EBITDA Margin 5 Yr. Avg. - 30.5 % 24.48 % 21.17 %
Operating Margin (Q4 MRQ) - 10.72 % 10.89 % 21.64 %
Operating Margin (Q4 TTM) - 12.04 % 10.86 % -13.31 %
Operating Margin 5 Yr. Avg. - 16.07 % 14.81 % 15.8 %
Pre-Tax Profit Margin (Q4 MRQ) - 9.73 % 7.79 % 10.74 %
Pre-Tax Profit Margin (Q4 TTM) - 8.42 % 6.25 % 11.25 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.74 % 11.27 % 11.1 %
Net Margin (Q4 MRQ) - 12.18 % 9.07 % 9.01 %
Net Margin (Q4 TTM) - 11.16 % 7.12 % 9.36 %
Net Margin 5 Yr. Avg. - 8.17 % 7.66 % 8.9 %